Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

The pragmatic role of FEF25-75 in asymptomatic subjects, allergic rhinitis, asthma, and in military setting.

Ciprandi G, Cirillo I.

Expert Rev Respir Med. 2019 Dec;13(12):1147-1151. doi: 10.1080/17476348.2019.1674649. Epub 2019 Oct 4.

PMID:
31564180
2.

Clustering analysis in outpatients with allergic rhinitis in clinical practice.

Ciprandi G, Silvestri M, Pistorio A, Tosca MA, Cirillo I.

Allergy. 2019 Mar;74(3):607-610. doi: 10.1111/all.13645. Epub 2018 Dec 3. No abstract available.

PMID:
30362571
3.

FEF25-75 and Asthma in Clinical Practice.

Ciprandi G, Gallo F, Cirillo I.

Iran J Allergy Asthma Immunol. 2018 Jun;17(3):295-297.

4.

Impaired spirometry may predict bronchial hyperresponsiveness.

Cirillo I, Gallo F, Ciprandi G.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):2127-2129.e2. doi: 10.1016/j.jaip.2018.02.030. Epub 2018 Mar 17. No abstract available.

PMID:
29559209
5.

Could routine spirometry suggest sensitisation in the military medicine setting?

Cirillo I, Gallo F, Ciprandi G.

J R Army Med Corps. 2018 Feb;164(1):58-60. doi: 10.1136/jramc-2017-000841. Epub 2017 Nov 24.

PMID:
29176005
6.

Fractional Exhaled Nitric Oxide: A Potential Biomarker in Allergic Rhinitis?

Ciprandi G, Gallo F, Ricciardolo FL, Cirillo I.

Int Arch Allergy Immunol. 2017;172(2):99-105. doi: 10.1159/000456548. Epub 2017 Mar 3.

PMID:
28253520
7.

The asthma control in daily practice.

Ciprandi G, Tosca MA, Cirillo I, Gallo F, Ricciardolo FL, Sadatsafavi M, Mark FitzGerald J.

Allergy. 2016 Jun;71(6):907-9. doi: 10.1111/all.12893. No abstract available.

PMID:
27168014
8.

Safety and Tolerability of Doripenem in Hospitalized Children With Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections and Pneumonia.

Cannavino CR, Castaneda-Ruiz B, Redman R, Go O, Cirillo I, Barauskas V, Senatorova G, Emeryk A, Bradley JS.

Pediatr Infect Dis J. 2015 Nov;34(11):1264-7. doi: 10.1097/INF.0000000000000859.

PMID:
26226440
9.

Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological Age.

Cirillo I, Vaccaro N, Castaneda-Ruiz B, Redman R, Cossey V, Bradley JS, Allegaert K.

Antimicrob Agents Chemother. 2015 Aug;59(8):4742-9. doi: 10.1128/AAC.00485-15. Epub 2015 May 26.

10.

The relevance of obesity on asthma control in identical twins.

Ciprandi G, Cirillo I, Ricciardolo FL.

Allergol Int. 2015 Jan;64(1):104-5. doi: 10.1016/j.alit.2014.08.007. Epub 2014 Dec 17. No abstract available.

11.

Allergic rhinitis phenotypes based on bronchial hyperreactivity to methacholine.

Ciprandi G, Ricciardolo FL, Schiavetti I, Cirillo I.

Am J Rhinol Allergy. 2014 Nov-Dec;28(6):214-8. doi: 10.2500/ajra.2014.28.4124.

PMID:
25514477
12.

Increased body mass index and bronchial impairment in allergic rhinitis.

Ciprandi G, Ricciardolo FL, Signori A, Schiavetti I, Monardo M, Ferraro MR, Cirillo I.

Am J Rhinol Allergy. 2013 Nov-Dec;27(6):e195-201. doi: 10.2500/ajra.2013.27.3979.

PMID:
24274214
13.

Extending the record of bis-γ-pyrone polypropionates from marine pulmonate mollusks.

Carbone M, Ciavatta ML, Wang JR, Cirillo I, Mathieu V, Kiss R, Mollo E, Guo YW, Gavagnin M.

J Nat Prod. 2013 Nov 22;76(11):2065-73. doi: 10.1021/np400483c. Epub 2013 Nov 1.

PMID:
24180210
14.

Increased body mass index and bronchial impairment in allergic rhinitis.

Ciprandi G, Ricciardolo FLM, Signori A, Schiavetti I, Monardo M, Rosaria Ferraro M, Cirillo I.

Am J Rhinol Allergy. 2013 Nov 1;27(6):195-201. doi: 10.2500/ajra.2013.27.3979.

PMID:
29021073
15.

Methacholine bronchial challenge effects on nasal symptoms and function in patients with allergic rhinitis.

Cirillo I, Medusei G, Signori A, Ciprandi G.

Eur Ann Allergy Clin Immunol. 2013 Aug 1;45(4):123-9.

PMID:
24067337
16.

FEF25-75: a marker for small airways and asthma control.

Ciprandi G, Cirillo I, Pasotti F, Ricciardolo FL.

Ann Allergy Asthma Immunol. 2013 Sep;111(3):233. doi: 10.1016/j.anai.2013.06.012. Epub 2013 Jul 16. No abstract available.

PMID:
23987209
17.

FEF25-75 should be carefully considered in allergic rhinitis.

Ciprandi G, Cirillo I.

Allergol Immunopathol (Madr). 2013 May-Jun;41(3):211. doi: 10.1016/j.aller.2013.01.003. Epub 2013 Mar 26. No abstract available.

PMID:
23537593
18.

Impaired FEF25-75 may predict high exhaled nitric oxide values in children with allergic rhinitis and/or asthma.

Ciprandi G, Tosca MA, Cirillo I, Lionetti E, Leonardi S, Miraglia Del Giudice M, La Rosa M, Salpietro A, Capasso M, Marseglia GL.

J Biol Regul Homeost Agents. 2012 Jan-Mar;26(1 Suppl):S27-33.

PMID:
22691247
19.

Impaired FEF25-75 values may predict bronchial reversibility in allergic children with rhinitis or asthma.

Ciprandi G, Capasso M, Leonardi S, Lionetti E, La Rosa M, Salpietro C, Miraglia Del Giudice M, Cirillo I, Tosca M, Marseglia GL.

J Biol Regul Homeost Agents. 2012 Jan-Mar;26(1 Suppl):S19-25.

PMID:
22691246
20.

Impaired spirometry may suggest sensitization.

Ciprandi G, Salpietro A, Leonardi S, Tosca MA, Miraglia Del Giudice M, Salpietro C, La Rosa M, Cirillo I, Signori A, Marseglia GL.

J Biol Regul Homeost Agents. 2012 Jan-Mar;26(1 Suppl):S15-7.

PMID:
22691245
21.

A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia.

Kollef MH, Chastre J, Clavel M, Restrepo MI, Michiels B, Kaniga K, Cirillo I, Kimko H, Redman R.

Crit Care. 2012 Nov 13;16(6):R218. doi: 10.1186/cc11862.

22.

Exhaled nitric oxide may predict bronchial hyperreactivity in patients with allergic rhinitis.

Cirillo I, Ricciardolo FL, Medusei G, Signori A, Ciprandi G.

Int Arch Allergy Immunol. 2013;160(3):322-8. doi: 10.1159/000341675. Epub 2012 Oct 9.

PMID:
23052027
23.

Doripenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy.

Samtani MN, Vaccaro N, Cirillo I, Matzke GR, Redman R, Nandy P.

ISRN Pharmacol. 2012;2012:782656. doi: 10.5402/2012/782656. Epub 2012 Jul 19.

24.

Spirometric abnormalities in patients with allergic rhinitis: Indicator of an "asthma march"?

Ciprandi G, Signori A, Tosca MA, Cirillo I.

Am J Rhinol Allergy. 2011 Sep-Oct;25(5):e181-5. doi: 10.2500/ajra.2011.25.3652.

PMID:
22186235
25.

Pharmacokinetics of single-dose doripenem in adults with cystic fibrosis.

Cirillo I, Vaccaro N, Redman R, Black PL, Kearns GL.

J Clin Pharmacol. 2012 Nov;52(11):1645-53. doi: 10.1177/0091270011427564. Epub 2011 Dec 14.

PMID:
22174436
26.

Monosensitization and polysensitization in allergic rhinitis.

Ciprandi G, Cirillo I.

Eur J Intern Med. 2011 Dec;22(6):e75-9. doi: 10.1016/j.ejim.2011.05.009. Epub 2011 Jun 8.

PMID:
22075317
27.

Visual analogue scale assessment of nasal obstruction might define patients candidates to spirometry.

Ciprandi G, Tosca MA, Signori A, Cirillo I.

Rhinology. 2011 Aug;49(3):292-6. doi: 10.4193/Rhino10.303.

PMID:
21858258
28.

Impact of allergic rhinitis on bronchi: an 8-year follow-up study.

Ciprandi G, Cirillo I, Signori A.

Am J Rhinol Allergy. 2011 Mar-Apr;25(2):e72-6. doi: 10.2500/ajra.2011.25.3607.

PMID:
21679504
29.

Relationship between bronchial hyperreactivity and bronchodilation in patients with allergic rhinitis.

Ciprandi G, Signori A, Cirillo I.

Ann Allergy Asthma Immunol. 2011 Jun;106(6):460-6. doi: 10.1016/j.anai.2011.03.001. Epub 2011 Apr 20.

PMID:
21624744
30.

Bronchial hyperreactivity in patients with allergic rhinitis: forced expiratory flow between 25 and 75% of vital capacity might be a predictive factor.

Ciprandi G, Tosca MA, Signori A, Cirillo I.

Allergy Asthma Proc. 2011 Mar-Apr;32(2):4-8. doi: 10.2500/aap.2011.32.3425.

PMID:
21439158
31.

Forced expiratory flow between 25% and 75% of vital capacity may be a marker of bronchial impairment in allergic rhinitis.

Ciprandi G, Cirillo I.

J Allergy Clin Immunol. 2011 Feb;127(2):549; discussion 550-1. doi: 10.1016/j.jaci.2010.10.053. No abstract available.

PMID:
21281879
32.

Bronchodilation test in patients with allergic rhinitis.

Ciprandi G, Signori A, Tosca MA, Cirillo I.

Allergy. 2011 May;66(5):694-8. doi: 10.1111/j.1398-9995.2011.02544.x. Epub 2011 Jan 25.

PMID:
21261662
33.

Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem.

Cirillo I, Vaccaro N, Balis D, Redman R, Matzke GR.

Antimicrob Agents Chemother. 2011 Mar;55(3):1187-93. doi: 10.1128/AAC.01063-10. Epub 2011 Jan 3.

34.

Assessment of the bronchodilation test by visual analog scale in the selection of patients with rhinitis for screening spirometry.

Ciprandi G, Quaglini S, Giunta V, Cirillo I.

J Investig Allergol Clin Immunol. 2010;20(5):419-24.

35.

Lower airways may also be affected in asymptomatic patients with recent onset of allergic rhinitis.

Ciprandi G, Cirillo I, Klersy C.

Laryngoscope. 2010 Jul;120(7):1288-91. doi: 10.1002/lary.20962.

PMID:
20578230
36.

Rupatadine improves nasal symptoms, airflow and inflammation in patients with persistent allergic rhinitis: a pilot study.

Ciprandi G, Cirillo I.

J Biol Regul Homeost Agents. 2010 Apr-Jun;24(2):177-83.

PMID:
20487631
37.

Visual analogue scale assessment of respiration might be a surrogate for spirometry in allergic rhinitis.

Ciprandi G, Caimmi S, Marseglia G, Tosca MA, Cirillo I.

J Biol Regul Homeost Agents. 2010 Jan-Mar;24(1):103-5.

PMID:
20385077
38.

Impact of allergic rhinitis on asthma in children: effects on bronchial hyperreactivity.

Ciprandi G, Tosca MA, Cirillo I, Capasso M.

Allergy. 2010 Sep;65(9):1199-201. doi: 10.1111/j.1398-9995.2009.02321.x. Epub 2010 Feb 4. No abstract available.

PMID:
20132159
39.

Pharmacokinetics, safety, and tolerability of doripenem after 0.5-, 1-, and 4-hour infusions in healthy volunteers.

Cirillo I, Vaccaro N, Turner K, Solanki B, Natarajan J, Redman R.

J Clin Pharmacol. 2009 Jul;49(7):798-806. doi: 10.1177/0091270009337012.

PMID:
19553404
40.

Employment status, aspirations and perceptions of support amongst psychiatric service users in Pavia, Italy.

Cirillo I, Politi P, Rampi E, Secker J, Brasia F, Severino A.

Epidemiol Psichiatr Soc. 2009 Jan-Mar;18(1):40-7.

PMID:
19378698
41.

Upper respiratory tract infections and sublingual immunotherapy: preliminary evidence.

Ciprandi G, Sormani MP, Cirillo I, Tosca M.

Ann Allergy Asthma Immunol. 2009 Mar;102(3):262-3. doi: 10.1016/S1081-1206(10)60095-6. No abstract available.

PMID:
19354079
42.

Ebastine increases IFN-gamma production in patients with persistent allergic rhinitis.

Ciprandi G, Cirillo I, Pistorio A, Di Gioacchino M, Fenoglio D.

J Biol Regul Homeost Agents. 2009 Jan-Mar;23(1):31-6.

PMID:
19321044
43.

Impact of allergic rhinitis on asthma: effects on bronchial hyperreactivity.

Cirillo I, Pistorio A, Tosca M, Ciprandi G.

Allergy. 2009 Mar;64(3):439-44. doi: 10.1111/j.1398-9995.2008.01851.x. Epub 2009 Jan 28.

PMID:
19175597
44.

Clinical assessment of a nasal decongestion test by visual analog scale in allergic rhinitis.

Ciprandi G, Klersy C, Ameli F, Cirillo I.

Am J Rhinol. 2008 Sep-Oct;22(5):502-5. doi: 10.2500/ajr.2008.22.3214.

PMID:
18954509
45.

Relationship between severity of rhinitis symptoms and nasal airflow.

Ciprandi G, Cirillo I, Pistorio A.

Rhinology. 2008 Sep;46(3):209-12.

PMID:
18853873
46.

Body mass index, respiratory function and bronchial hyperreactivity in allergic rhinitis and asthma.

Ciprandi G, Pistorio A, Tosca M, Ferraro MR, Cirillo I.

Respir Med. 2009 Feb;103(2):289-95. doi: 10.1016/j.rmed.2008.08.008. Epub 2008 Sep 24.

47.

Impact of allergic rhinitis on asthma: effects on bronchodilation testing.

Ciprandi G, Cirillo I, Pistorio A, La Grutta S, Tosca M.

Ann Allergy Asthma Immunol. 2008 Jul;101(1):42-6. doi: 10.1016/S1081-1206(10)60833-2.

PMID:
18681083
48.

Disposition, metabolism, and excretion of [14C]doripenem after a single 500-milligram intravenous infusion in healthy men.

Cirillo I, Mannens G, Janssen C, Vermeir M, Cuyckens F, Desai-Krieger D, Vaccaro N, Kao LM, Devineni D, Redman R, Turner K.

Antimicrob Agents Chemother. 2008 Oct;52(10):3478-83. doi: 10.1128/AAC.00424-08. Epub 2008 Jul 21.

49.

Relationship between rhinitis duration and worsening of nasal function.

Ciprandi G, Cirillo I, Pistorio A, La Grutta S.

Otolaryngol Head Neck Surg. 2008 Jun;138(6):725-9. doi: 10.1016/j.otohns.2008.03.027.

PMID:
18503843
50.

Relationship between rhinitis duration and response to nasal decongestion test.

Ciprandi G, Pistorio A, Tosca M, Cirillo I.

Laryngoscope. 2008 Jul;118(7):1139-41. doi: 10.1097/MLG.0b013e3181715160.

PMID:
18425049

Supplemental Content

Loading ...
Support Center